This page holds a finished NR 566 Week 6 medication review, reproduced in full, with each proposed reduction argued as carefully as a new prescription would be. Searches like "nr 566 week 6 assignment example", "nr566 week 6 sample" and "nr 566 week 6 example" land here.
What a finished NR 566 Week 6 medication review looks like
The list is rearranged by indication before anything else happens, and two agents doing one job become visible at once. A cascade turns up: ankle swelling from a calcium channel blocker earned a diuretic, the diuretic earned a potassium supplement, and nobody stopped the first drug. Clearance is estimated rather than read off a normal looking creatinine, which in a thin eighty year old flatters the kidney badly. Anticholinergic load is totaled across the whole list instead of judged drug by drug, which is how three mild offenders add up to a fall. Beers and the STOPP criteria appear as reasoning, with the stated concern set against the specific agent in this patient, rather than as a badge pinned to a recommendation that would have been made anyway.
How a NR 566 Week 6 example is structured
Templates differ and many classrooms supply a table with fixed columns. The example opens on the person rather than the list, with function, falls, cognition and who actually fills the pill box. The table follows: agent, dose, indication, prescriber and start date where it is known. Findings come next in order of harm, covering duplication, the cascade, drugs with no remaining indication, doses above what the kidney can handle, and cumulative anticholinergic burden. Recommendations are sequenced rather than simultaneous, each carrying a taper where one is needed, a monitoring plan and the prescriber who has to be told about it. Anything the review proposes to add, rather than remove, sits in the same section and is defended on the same terms. The patient's own priorities appear before the conclusion, since a plan ignoring what the person wants rarely survives contact with them, and references close it.
The person before the list
Function, falls, cognition and who manages the box at home, because a list read without those facts produces recommendations nobody can carry out.
Sorted by indication
The table rearranged so that each condition gathers its agents together, which is what makes duplication and orphaned prescriptions visible on one page.
Finding the cascade
A side effect treated as a new diagnosis, traced back to the agent that started it, which is the single most satisfying finding in this assignment.
Clearance, not creatinine
An estimated filtration figure calculated for a patient with little muscle left, then used to test whether current doses are actually deliverable.
Changes in sequence
One alteration at a time, with a taper where withdrawal is a risk, so that any change in the patient can be attributed to something specific.
Who has to be told
The other prescribers, the pharmacy and the family member managing doses, named explicitly, since a reduction nobody hears about quietly reverses itself.
Where marks go in NR 566 Week 6
Top of the list is the review that identifies six problems and recommends nothing, or writes discuss with the provider beside each of them, which hands the decision back and earns no points. Second is stopping five agents at once with no sequence and no taper, which makes any resulting change impossible to attribute. Then: Beers cited as though the name settled the argument; a normal creatinine mistaken for normal clearance; a drug with no indication left untouched; nothing said about the four prescribers or the pharmacy that fills for all of them; the patient's own goals absent entirely; a supplement or an over the counter product ignored because it was not on the prescribed list; and a recommendation with no follow up interval attached to it.
Get a NR 566 Week 6 example written to your instructions
Send the Week 6 case with the medication list your classroom supplies and any review template it requires, and a custom example is written to that list and returned inside 24 to 48 hours. The first one is free, and which reductions you would defend stays your own clinical judgment.
NR 566 Week 6 questions, answered
Is deprescribing really the expected answer?
Often, though not automatically, and the reasoning is what carries the grade rather than the direction. Some reviews properly end by adding an agent that is missing, such as an overdue preventive therapy. What the week rewards is treating a removal with the same rigor as a start: an indication reviewed, a taper considered, a monitoring plan written and a review date set.
How are the Beers criteria used well?
As an argument rather than as an authority. Naming a drug as potentially inappropriate settles nothing on its own, since the criteria describe why an agent is a concern in older adults and leave the individual judgment open. The stronger paper states the specific concern, connects it to something in this patient, and then says what happens instead.
What if a medication has no documented indication?
That is a finding, and it is written up as one rather than assumed away. The realistic recommendation is to establish why it was started before removing it, since old records or another prescriber may hold the answer. Where no indication can be found and the agent carries risk in older adults, a tapered withdrawal with monitoring is a defensible plan.